SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Violations of Federal Securities Laws ...
January 21 2016 - 1:05PM
Business Wire
Levi & Korsinsky announces it has commenced an investigation
of Alkermes plc (NASDAQGS: ALKS) concerning possible violations of
federal securities laws by the Company and/or certain of its
officers and directors.
On January 21, 2016, Alkermes announced that its depression
treatment ALKS 5461 did not meet the primary efficacy endpoints in
two Phase 3 trials. Following this news, shares of Alkermes were
down 41.90% on intraday trading on January 21, 2016. To obtain
additional information, go to:
http://zlkdocs.com/ALKS-Info-Request-Form-3884
or contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877)
363-5972.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, Connecticut and Washington D.C. The firm’s
attorneys have extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits.
Attorney advertising. Prior results do not guarantee similar
outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160121006222/en/
Levi & Korsinsky, LLPEduard Korsinsky, Esq.Tel:
212-363-7500Toll Free: 877-363-5972Fax: 866-367-6510www.zlk.com
Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From Apr 2023 to Apr 2024